CD7+ CD56 + AML might constitute a distinct biologic and clinical disease entity. Our data showed that CD7+CD56+ AML associated with less anemia, overexpression of PgP and CD34 and a high incidence of central nervous system involvement.
英
美
- CD7+CD56+AML具有獨特的臨床生物學(xué)特征,較少貧血,高表達PgP和CD34,常伴有中樞神經(jīng)系統浸潤。